1. Malcovati, Luca, Stevenson, Kristen, Papaemmanuil, Elli, Hellstrom-Lindberg, Eva, Cazzola, Mario. . SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. In Blood, 136, 157-170. doi:10.1182/blood.2020004850. https://pubmed.ncbi.nlm.nih.gov/32347921/
2. Ochi, Tetsuro, Fujiwara, Tohru, Ono, Koya, Nakamura, Yukio, Harigae, Hideo. 2022. Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome. In Scientific reports, 12, 14562. doi:10.1038/s41598-022-18921-2. https://pubmed.ncbi.nlm.nih.gov/36028755/
3. Wang, Shourong, Liu, Yao, Xiao, Huimin, Sun, Chaoyang, Song, Kun. 2023. Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer. In Cell death & disease, 14, 775. doi:10.1038/s41419-023-06301-1. https://pubmed.ncbi.nlm.nih.gov/38012150/
4. Rombaut, David, Lefèvre, Carine, Rached, Tony, Chédin, Frédéric, Fontenay, Michaela. 2024. Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation. In Nature communications, 15, 3016. doi:10.1038/s41467-024-46547-7. https://pubmed.ncbi.nlm.nih.gov/38589367/
5. Pollyea, Daniel A, Kim, Hyun Min, Stevens, Brett M, Tan, Aik Choon, Alper, Scott. 2020. MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells. In Journal of leukocyte biology, 110, 197-205. doi:10.1002/JLB.6AB0520-318RR. https://pubmed.ncbi.nlm.nih.gov/33155727/
6. Nassar, Kelsey W, Tan, Aik Choon. 2019. The mutational landscape of mucosal melanoma. In Seminars in cancer biology, 61, 139-148. doi:10.1016/j.semcancer.2019.09.013. https://pubmed.ncbi.nlm.nih.gov/31655118/
智鼠故事 
